Clinical Trials Logo

Clinical Trial Summary

This study is a randomized controlled clinical trial to compare the pregnancy outcomes of infertile women with frozen embryo transfer. The study population in frozen embryo transfer cycles receive three doses of human chorionic gonadotropin (HCG) to recognize the effectiveness of HCG on pregnancy outcomes in Reproductive Biomedicine Research Center, Royan institute, Tehran Iran.


Clinical Trial Description

During implantation, the biochemical crosstalk between the endometrium and embryo has a very important role. The endometrium secrets cytokines and growth factors that modulate embryonic differentiation and early development. One of the important molecular messages between the embryo and endometrium is human chorionic gonadotropin (HCG). HCG is expressed by the blastocyst before the implantation, while increasingly produced after implantation by the syncytiotrophoblast. In order to study the direct effect of HCG on the endometrium at implantation, this randomized, controlled clinical trial evaluated whether HCG supplementation would be beneficial for pregnancy outcomes of cryopreserved-thawed embryo transfer with estrogen/ progesterone replacement cycles at Royan Institute. Block randomization method is designed by epidemiologist using STATA software version 13 and the number of blocks considered is 6. The random allocation list for patients is solely available to the epidemiologist. In order to hide the random allocation process, a total of 200 envelopes are prepared, and only the methodologist has been aware of table of random numbers. When the doctor declared the patient's eligibility, the methodologist provided the doctor with the envelope. The group will be selected and based on the type of group mentioned in the envelope. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04855383
Study type Interventional
Source Royan Institute
Contact Parvaneh Afsharian, PhD
Phone +982123562674
Email [email protected]
Status Recruiting
Phase N/A
Start date July 1, 2020
Completion date September 21, 2022

See also
  Status Clinical Trial Phase
Completed NCT02032797 - Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone. Phase 4
Recruiting NCT04077970 - Intrauterine Flushing With Follicular Fluid Plus Granulosa Cells Phase 3
Terminated NCT00588250 - Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates N/A
Completed NCT03485235 - Effect of Dilatation and Curettage on the Endometrial Receptivity N/A
Recruiting NCT02072291 - Nifedipine Treatment on Uterine Contractility in IVF Phase 2
Completed NCT02815371 - Laser Acupuncture Before and After Embryo Transfer Improves IVF Outcomes N/A
Recruiting NCT04003337 - Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation. N/A
Completed NCT02407730 - EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies
Completed NCT00635258 - Administration of GnRH Antagonist to Oocyte Donation Recipients N/A
Completed NCT03108157 - Endometrial Scratch Effect on Pregnancy Rates in Patients Undergoing Egg-donation IVF N/A
Enrolling by invitation NCT04744844 - DNA Amplification in Blastocoel Fluid N/A
Recruiting NCT04159649 - The Outcomes of ICSI Cycles With and Without Letrozole Phase 4
Not yet recruiting NCT00506480 - Assessment of Endometrial Receptivity in Recipients of Donated Oocytes N/A
Completed NCT03128970 - Synchronizing Blastocyst in Frozen Embryo Transfer N/A